KPT-9274
Showing 1 - 25 of 36
Solid Tumors, NHL Trial in Canada, United States (KPT-9274, Niacin ER, Nivolumab)
Terminated
- Solid Tumors
- NHL
- KPT-9274
- +2 more
-
Los Angeles, California
- +7 more
Jan 18, 2023
Acute Myeloid Leukemia, Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory Trial in Aurora (KPT-9274)
Recruiting
- Acute Myeloid Leukemia
- +2 more
- KPT-9274
-
Aurora, Colorado
- +1 more
Aug 30, 2021
Solid Tumor, Non-Hodgkin's Lymphoma Trial in China, Taiwan (ATG-019, ATG-019 + Niacin ER)
Recruiting
- Solid Tumor, Non-Hodgkin's Lymphoma
- ATG-019
- ATG-019 + Niacin ER
-
Nanjing, Jiangsu, China
- +7 more
Aug 11, 2022
Acute Myeloid Leukemia (AML) Trial in Worldwide (Selinexor, Hydroxyurea, Ara-C)
Completed
- Acute Myeloid Leukemia (AML)
- Selinexor
- +2 more
-
Los Angeles, California
- +77 more
Jan 24, 2023
Multiple Myeloma in Relapse Trial in Aurora (Selinexor, Pomalidomide, Daratumumab)
Recruiting
- Multiple Myeloma in Relapse
- Selinexor
- +4 more
-
Aurora, ColoradoUniversity of Colorado Hospital
Jan 31, 2023
Solid Tumor Malignancy Trial in Hackensack (Selinexor, Irinotecan)
Withdrawn
- Solid Tumor Malignancy
-
Hackensack, New JerseyJohn Theurer Cancer Center at HackensackUMC
Dec 14, 2021
Recurrent Melanoma Trial in Columbus (selinexor, Correlative studies)
Active, not recruiting
- Recurrent Melanoma
- selinexor
- Correlative studies
-
Columbus, OhioArthur G. James Cancer Hospital and Solove Research Institute at
Sep 5, 2022
Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Stage IV Pancreatic Cancer Trial in
Suspended
- Acinar Cell Adenocarcinoma of the Pancreas
- +2 more
- gemcitabine hydrochloride
- +4 more
-
Detroit, Michigan
- +1 more
Feb 2, 2022
Soft Tissue Sarcoma Trial in Toronto (Selinexor, Doxorubicin)
Completed
- Soft Tissue Sarcoma
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Nov 26, 2021
MDS Trial in New York (selinexor (KPT-330))
Completed
- Myelodysplastic Syndromes
- selinexor (KPT-330)
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Feb 11, 2022
Coronavirus Infection Trial in Worldwide (Selinexor, Placebo)
Gliosarcoma, Newly Diagnosed, Glioblastoma Trial run by the National Cancer Institute (NCI) (Selinexor, Temozolomide, Generic
Recruiting
- Gliosarcoma
- +2 more
- Selinexor
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Apr 7, 2022
Prostate Cancer Trial in Houston (Selinexor)
Terminated
- Prostate Cancer
-
Houston, TexasM.D. Anderson Cancer Center
Jan 7, 2021
Multiple Myeloma Trial in Washington, Hackensack (Selinexor 60 MG, Selinexor 80 MG, Selinexor 100 MG)
Recruiting
- Multiple Myeloma
- Selinexor 60 MG
- +6 more
-
Washington, District of Columbia
- +1 more
Feb 3, 2022
Ovarian Cancer, Endometrial Cancer Trial in Middletown, Harrison, New York (Paclitaxel, Carboplatin, Selinexor)
Completed
- Ovarian Cancer
- Endometrial Cancer
- Paclitaxel
- +2 more
-
Middletown, New Jersey
- +2 more
Apr 22, 2021
Healthy Trial in Melbourne (Verdinexor, Placebo)
Breast Cancer Trial in Tampa (Selinexor)
Completed
- Breast Cancer
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Sep 9, 2020
Multiple Myeloma, Relapsed and/or Refractory Multiple Myeloma Trial in United States (Selinexor, Ixazomib, Dexamethasone)
Completed
- Multiple Myeloma
- Relapsed and/or Refractory Multiple Myeloma
- Selinexor
- +2 more
-
Basking Ridge, New Jersey
- +6 more
Nov 23, 2020
Peripheral T-cell Lymphoma Trial in Singapore (Selinexor, ICE Chemotherapy)
Completed
- Peripheral T-cell Lymphoma
- Selinexor
- ICE Chemotherapy
-
Singapore, SingaporeNational Cancer Centre Singapore
Apr 27, 2021